Introduction
The incidence of epidemics of measles has decreased recently because of the development and widespread use of measles vaccine in the United States of America and Europe. However, despite mass vaccination programs, there have been repeated measles epidemics in Japan. Owing to the lack of complete vaccination coverage and primary and secondary failures of vaccine, the risk of measles infection in women of childbearing age during measles epidemics has increased.
Although there have been reports of some cases of perinatal measles, 1 there have been no reports of measles infection in extremely low body weight infants. Here, we report a case of extremely low body weight infant found positive for measles by real-time PCR.
Case
The mother is a 31-year-old woman who was Gravida 2 Para 2. In the twenty-fourth gestational week, she developed exanthema and fever, and measles was diagnosed on the basis of clinical manifestations at the outpatient clinic of a local general hospital in Fukushima, Japan. She had not experienced measles or received a vaccination. Two days after being diagnosed with measles, she was admitted to the hospital for preterm delivery. She gave birth to a female infant by spontaneous delivery on the same day.
The infant was born at 24 weeks and weighed 592 g. The Apgar score was 1 and 5 at 1 and 5 min after birth, respectively. Shortly after birth, the infant was observed to have severe respiratory depression requiring endotracheal intubation and mechanical ventilation. The infant was diagnosed with respiratory distress syndrome by X-ray and received surfactant therapy. Though the infant was born on the second day after the appearance of exanthema in her mother, she had no exanthema. She was immediately transferred to the University Hospital of Fukushima Medical University, Fukushima Japan for general control in the neonatal intensive care unit, where she received immune serum globulin on the day of birth (Day 0). She developed pulmonary interstitial emphysema with the right pneumothrax requiring chest tube placement on Day 1 after birth. She had a patent ductus arteriosus that was not closed by indomethacin treatment, so that she needed surgical ligation for closure of the patent ductus arteriosus on Day 5 after birth. Circulation was improved after surgical ligation. To detect measles virus from the infant clinical samples, endotracheal secretion, urine, skin, anal and nasopharyngeal swabs were collected on Days 0 (at birth), 1, 3, 4, 5, 6, 7, 8, 9 and 14. The mother's serum and breast milk samples, and throat swabs were collected on Days 1, 7 and 14 after birth of the child (Table 1 , on-line supplement). Serum specimens were tested for the presence of measles-specific immunoglobulin (Ig)M and IgG antibodies using an enzyme-linked immuno sorbent assay (Table 2) . Measles virus RNA was extracted from clinical samples from the infant and mother, and real-time PCR assays for measles virus were carried out. Measles virus was detected at very low levels in her cord blood serum at birth, but had vanished from clinical samples within a couple of days. The amount of virus in the blood stream serum taken on Day 3 was about 1/100 that in the cord blood serum on Day 0. Measles virus was not detected in the sputa, skin or serum from the infant after Day 4. The amount of measles virus in the mother's breast milk was markedly higher than in the cord blood. Serological analysis in infant was negative for measles-specific IgM throughout the clinical course. The samples were positive for measles-specific IgG at only a low level at birth; however, the samples were found to be positive for IgG antibodies against measles on Day 7 and 41 after birth (Table 2) .
Discussion
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2 first reported congenital measles in a 1760-g premature infant. However, this is the first report of a low birth weight infant born to a mother with measles. The effects of measles are largely limited to prematurely born infants, and measles is not associated with any significant increase in fetal deaths. 3 However, Eberhart 4 reported that measles in pregnancy might lead to high rates of fetal loss and prematurity, particularly in the first 2 weeks after the onset of a rash. They also reported that no newborns had been diagnosed with congenital measles and no newborn had measles in the first month of life. They did not, however, carry out serological tests for measles infection.
Maternal IgG begins to transfer to the fetus from the eighth weeks of gestation, and the levels of maternal IgG in the fetus is almost by itself 200 mg 100 ml À1 at 24 weeks of gestation. On the other hand, a fetus begins to produce IgG by itself after 20 weeks of gestation, and even at 32 weeks of gestation, the level of fetal IgG is almost 25 mg 100 ml À1 . Premature birth cuts short the transplacental transfer of maternal IgG 5 at the third trimester, so that the baby lacks passive maternal protection against measles before the third trimester, though a fetus can produce IgM by itself after 8 weeks of gestation. 6 As passive immunity, Christensen et al. 7 reported that 7 out of 22 cases of congenital measles on not receiving g-globulin died. In our case, the mother gave birth within 3 days after the onset of the rash, and the baby did not have a rash at birth. IgG antibodies against measles virus were detected at birth, though at an extremely low level. The increasing level of IgG against measles observed in the infant was due to the administration of pooled g-globulin.
As no measles-specific IgM was detected, we presumed that infection with measles was not completed, though the measles virus was detected in the blood stream of the infant by PCR. Bhat et al. 10 suggested that, in hepatitis B virus, placental maturity may protect the fetus from hepatitis B virus. And Hideki Koi et al. 8 showed that in Herpes Simplex Virus, the villous syncytiotrophoblast forms an effective barrier preventing transplacental transmission of Herpes Simplex Virus to the fetus from infection. In our case, the amount of measles virus in mother's samples was extremely high compared with that in the infant's samples, suggesting that trophoblasts might have a defensive role in transplacental infection. The quantitative real-time PCR was carried out by the following procedure: RNA was extracted from 250 ml of each samples by IsoGene (NipponGene, Tokyo, Japan), then resolved in 20 ml of H 2 O. Each swab was taken and washed in 4 ml of 2% fetal calf serum supplemented minimal essential medium. In all, 5 ml of RNA solution was used for the reverse transcription reaction with PrimeScript RT reagent Kit (Takara, Shiga, Japan) with 10 ml of final volume. Two ml of c-DNA solution was used for real-time PCR of P gene of measles virus 11 using the SYBR Green method (Takara, Shiga, Japan). Thermal cycler conditions: the reactions were incubated for 10 s denaturation at 95 1C; then the reactions were run for 40 cycles of denaturation for 5 s at 95 1C and extension for 31 s at 60 1C per cycle using the ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The real-time PCR data was analyzed using the standard curve method with serial diluted measles virus. Copi number of measles P gene is represented in measles virus titer, Tissue Culture Infectious Dose 50 (TCID 50 ). a At birth. b The Ct value was over 37.
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